• Home
Scientific article
English

Clinical impact of 18F-choline PET/CT in patients with recurrent prostate cancer

ContributorsSoyka, Jan D; Muster, Marco A; Schmid, Daniel T; Seifert, Burkhardt; Schick, Ulrike; Miralbell, Raymond; Jorcano, Sandra; Zaugg, Kathrin; Seifert, Hans-Helge; Veit-Haibach, Patrick; Strobel, Klaus; Schaefer, Niklaus G; Husarik, Daniela B; Hany, Thomas F
Published inEuropean journal of nuclear medicine and molecular imaging, vol. 39, no. 6, p. 936-943
Publication date2012
Abstract

To investigate the clinical value of (18)F-fluorocholine PET/CT (CH-PET/CT) in treatment decisions in patients with recurrent prostate cancer (rPCA).

Keywords
  • Adult
  • Aged
  • Choline/analogs & derivatives/diagnostic use
  • Humans
  • Male
  • Middle Aged
  • Positron-Emission Tomography and Computed Tomography
  • Prostate-Specific Antigen/metabolism
  • Prostatic Neoplasms/metabolism/radionuclide imaging/therapy
  • Recurrence
  • Retrospective Studies
Affiliation entities
Research groups
Citation (ISO format)
SOYKA, Jan D et al. Clinical impact of 18F-choline PET/CT in patients with recurrent prostate cancer. In: European journal of nuclear medicine and molecular imaging, 2012, vol. 39, n° 6, p. 936–943. doi: 10.1007/s00259-012-2083-2
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
Journal ISSN1619-7070
477views
1downloads

Technical informations

Creation31/10/2013 19:53:00
First validation31/10/2013 19:53:00
Update time14/03/2023 21:42:53
Status update14/03/2023 21:42:52
Last indexation30/10/2024 16:20:51
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack